Cost-effectiveness Analysis of Cefepime and Ceftazidime in Treatment of Bacterial Infections

Keywords

Cefepime, Ceftazidime, Medicine, Dose, Intensive care medicine

References

No references recorded for this paper.

Cited by

No citing papers recorded for this paper.

Related papers

• A Cost-effect Analysis of Cefepime and Ceftazidime in the Treatment of Respiratory Tract InfectionsTan Xian — 2002
• Comparative study of the efficacy of Cefepime and Ceftazidime in treating serious lower respiratory tract infectionsXu Zi — 2001
• Evaluation of clinical therapeutic effect of cefepime in treating lower repiratory tract infectionsShu Sun — 2000
• A randomized controlled clinical study of cefepime versus ceftazidime in the treatment of 129 patients with bacterial infectionsGuanghui Li — 2000
• Cefepime versus ceftazidime for the treatment of serious bacterial infections.Alfredo Ponce‐de‐León, Mauricio López–Meneses, José Sifuentes‐Osornio — 1999
• Cefepime versus ceftazidime in the treatment of lower respiratory tract infections.Antonio Aufiero, C Sturani, P. Zanona — 1997
• A meta-analysis of the treatment of lower respiratory tract infection with randomized control study of Cefepime and CeftazidimeLi Yin — 2009
• Clinical evaluation of cefepime in treatment of lower respiratory tract bacterial infectionsYing Tang — 2001
• A randomized trial of cefepime and ceftazidime for the treatment of community-acquired pneumonia.Pedro Henrique Leite Bonfitto, V. Lamorgese, T. De Vietro — 1999
• Phase IV trials of cefepime in treat-ment of various moderate or severe bacterial infectionsPang Mao-yin — 2002